Evidence map›Paper›PMID 37671023›Full record

ArticleCell reports methods2023

The design of functional proteins using tensorized energy calculations.

Kateryna Maksymenko, Andreas Maurer, Narges Aghaallaei, Caroline Barry, Natalia Borbarán-Bravo, Timo Ullrich, Tjeerd M H Dijkstra, Birte Hernandez Alvarez, Patrick Müller, Andrei N Lupas and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports methods, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Tuning of G-CSFR signaling by de novo-designed agonists.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  3. A Complementarity-Based Approach to De Novo Binder Design.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Kateryna MaksymenkoDepartment of Protein Evolution, Max Planck Institute for Biology, 72076 Tübingen, Germany.
Andreas MaurerWerner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, 72076 Tübingen, Germany.
Narges AghaallaeiDivision of Translational Oncology, University Hospital Tübingen, 72076 Tübingen, Germany.
Caroline BarryDepartment of Protein Evolution, Max Planck Institute for Biology, 72076 Tübingen, Germany.
Natalia Borbarán-BravoDivision of Translational Oncology, University Hospital Tübingen, 72076 Tübingen, Germany.
Timo UllrichDepartment of Protein Evolution, Max Planck Institute for Biology, 72076 Tübingen, Germany.
Tjeerd M H DijkstraDepartment of Protein Evolution, Max Planck Institute for Biology, 72076 Tübingen, Germany.
Birte Hernandez AlvarezDepartment of Protein Evolution, Max Planck Institute for Biology, 72076 Tübingen, Germany.
Patrick MüllerFriedrich Miescher Laboratory of the Max Planck Society, 72076 Tübingen, Germany.
Andrei N LupasDepartment of Protein Evolution, Max Planck Institute for Biology, 72076 Tübingen, Germany.
Julia SkokowaDivision of Translational Oncology, University Hospital Tübingen, 72076 Tübingen, Germany.
Mohammad ElGamacyDepartment of Protein Evolution, Max Planck Institute for Biology, 72076 Tübingen, Germany.
Max Planck Society · DEUniversity Children's Hospital Tübingen · DEMax Planck Institute for Biology · DEJohns Hopkins University · USSiemens (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In protein design, the energy associated with a huge number of sequence-conformer perturbations has to be routinely estimated. Hence, enhancing the throughput and accuracy of these energy calculations can profoundly improve design success rates and enable tackling more complex design problems. In this work, we explore the possibility of tensorizing the energy calculations and apply them in a protein design framework. We use this framework to design enhanced proteins with anti-cancer and radio-tracing functions. Particularly, we designed multispecific binders against ligands of the epidermal growth factor receptor (EGFR), where the tested design could inhibit EGFR activity

Indexed as

Copper RadioisotopesErbB ReceptorsEye, ArtificialOrthotic DevicesPhosphorylationCopper RadioisotopesErbB Receptorscopper binderdiscrete rotamer samplingEGFR inhibitorenergy calculationprotein design

Identifiers

PMID37671023
PMCPMC10475850
OpenAlexW4385841262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.